A role for caveolae in multidrug resistance of cancer cells

被引：0
|
作者：
Lavie, Y [1 ]
Liscovitch, M [1 ]
机构：
[1] WEIZMANN INST SCI,DEPT REGULAT BIOL,IL-76100 REHOVOT,ISRAEL
来源：
MOLECULAR BIOLOGY OF THE CELL | 1997年 / 8卷
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：1199 / 1199
页数：1
相关论文
共 50 条
  • [31] The role of interaction of mevastatin with different membrane components in reversing multidrug resistance of colon cancer cells
    Sroda-Pomianek, K.
    Palko-Labuz, A.
    Wesolowska, O.
    Michalak, K.
    FEBS JOURNAL, 2012, 279 : 253 - 253
  • [32] MULTIDRUG RESISTANCE IN CANCER
    KARTNER, N
    LING, V
    SCIENTIFIC AMERICAN, 1989, 260 (03) : 44 - 51
  • [33] Cancer multidrug resistance
    Aris Persidis
    Nature Biotechnology, 1999, 17 : 94 - 95
  • [34] Cancer multidrug resistance
    不详
    Nature Biotechnology, 2000, 18 (Suppl 10) : IT18 - IT20
  • [35] Cancer multidrug resistance
    Persidis, A
    NATURE BIOTECHNOLOGY, 1999, 17 (01) : 94 - 95
  • [36] The role of MRP1 in the multidrug resistance of colorectal cancer
    Cao, Dongxing
    Qin, Shaolan
    Mu, Yifei
    Zhong, Ming
    ONCOLOGY LETTERS, 2017, 13 (04) : 2471 - 2476
  • [37] MULTIDRUG RESISTANCE IN CANCER
    不详
    LANCET, 1989, 2 (8671): : 1075 - 1076
  • [38] Role of Nanotechnology in Overcoming the Multidrug Resistance in Cancer Therapy: A Review
    Mir, Suhail Ahmad
    Hamid, Laraibah
    Bader, Ghulam Nabi
    Shoaib, Ambreen
    Rahamathulla, Mohamed
    Alshahrani, Mohammad Y.
    Alam, Prawez
    Shakeel, Faiyaz
    MOLECULES, 2022, 27 (19):
  • [39] The role of proton dynamics in the development and maintenance of multidrug resistance in cancer
    Daniel, Chloe
    Bell, Charlotte
    Burton, Christopher
    Harguindey, Salvador
    Reshkin, Stephan J.
    Rauch, Cyril
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2013, 1832 (05): : 606 - 617
  • [40] Multidrug resistance in cancer: Role of ATP-dependent transporters
    Gottesman, MM
    Fojo, T
    Bates, SE
    NATURE REVIEWS CANCER, 2002, 2 (01) : 48 - 58
12345